Thermo Fisher Scientific reported $377.49M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Abbott USD 25.12B 28M Mar/2025
Agilent USD 283.59M 280.59M Jul/2025
Becton, Dickinson and Co. USD 370.59M 406K Jun/2025
Bio Techne USD 156.76M 155.19M Jun/2025
Bio-Rad Laboratories USD 27.06M 27.06M Jun/2025
Boston Scientific USD 17M 0 Mar/2025
Bruker USD 151.72M 149.92M Jun/2025
Charles River Laboratories USD 49.21M 48.7M Jun/2025
Danaher USD 715.9M 706.9M Jun/2025
Dentsply International USD 199.3M 196.3M Jun/2025
Edwards Lifesciences USD 654.8M 500K Dec/2024
Exact Sciences USD 189.22M 187.33M Jun/2025
General Electric Aerospace USD 1.06B 1.05B Jun/2025
Henry Schein USD 121.9M 120.9M Jun/2025
Hologic USD 222.22M 219.22M Jun/2025
Illumina USD 154M 152M Jun/2025
Intuitive Surgical USD 358.42M 358.02M Jun/2025
IQVIA Holdings USD 170M 167.42M Jun/2025
Laboratory Of America USD 82.9M 75.3M Jun/2025
Medtronic USD 128K 128K Apr/2025
Mettler Toledo International USD 20.6M 20.15M Jun/2025
Myriad Genetics USD 900K 0 Mar/2025
Olympus JPY 1.13B 123.51B Jun/2025
Quest Diagnostics USD 112M 110M Jun/2025
Repligen USD 562K 1000 Mar/2025
Revvity USD 117.87M 2.78M Jun/2025
Stryker USD 382.3M 344.3M Jun/2025
Thermo Fisher Scientific USD 377.49M 66.51M Jun/2025
Veracyte USD 78.32M 78.24M Jun/2025
Waters USD 59.51M 57.88M Jun/2025
Zimmer Biomet Holdings USD 197.9M 194.7M Jun/2025